Veeva Systems Stock (NYSE:VEEV)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$218.00

52W Range

$170.25 - $258.93

50D Avg

$229.69

200D Avg

$214.94

Market Cap

$36.39B

Avg Vol (3M)

$1.28M

Beta

1.05

Div Yield

-

VEEV Company Profile


Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

7,291

IPO Date

Oct 16, 2013

Website

VEEV Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJan 25Jan 24Jan 23
Professional Services Veeva Commercial Cloud$185.30M$185.98M-
Professional Services Veeva Research And Development$276.66M$276.10M-
Subscription Services Veeva Research And Development$1.18B$905.79M-
Subscription Services Veeva Commercial Cloud$1.10B$995.80M-
Subscription and Circulation$2.28B$1.90B$1.66B
Technology Service$461.96M$462.08M$422.06M
Professional Services Commercial Solutions--$177.19M
Subscription Services R&D Solutions--$786.75M
Professional Services R&D Solutions--$244.87M
Subscription Services Commercial Solutions--$946.25M

Fiscal year ends in Jan 25 | Currency in USD

VEEV Financial Summary


Jan 25Jan 24Jan 23
Revenue$2.75B$2.36B$2.16B
Operating Income$691.43M$429.33M$459.09M
Net Income$714.14M$525.71M$487.71M
EBITDA$691.43M$461.96M$488.21M
Basic EPS$4.41$3.27$3.14
Diluted EPS$4.32$3.22$3.00

Fiscal year ends in Jan 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Mar 05, 25 | 5:00 PM
Q3 25Dec 05, 24 | 5:00 PM
Q2 25Aug 28, 24 | 5:00 PM

Peer Comparison


TickerCompany
ACCDAccolade, Inc.
SDGRSchrödinger, Inc.
PGNYProgyny, Inc.
AMWLAmerican Well Corporation
GDRXGoodRx Holdings, Inc.
CERTCertara, Inc.
GEHCGE HealthCare Technologies Inc.
TDOCTeladoc Health, Inc.
HQYHealthEquity, Inc.
TXG10x Genomics, Inc.
DOCSDoximity, Inc.